IP Library Granted Patent US 9,932,621
Granted Patent B2
US 9,932,621 · App. 13/808,706 · Granted Apr 3, 2018

Modulators for Sirt5 and assays for screening same

Inventor: Hening Lin (New York, NY)
Assignee: CORNELL UNIVERSITY
C12Q1/37A61K31/197C07D233/70C07D233/80C07D233/84C07D233/90C07D235/04C07D239/56C07D239/70C07D243/04C07D285/24C07D401/06C07D405/06C07D409/04C07D471/04C07D491/052C07D495/04C07D513/04C07K7/06C07K14/47C12Q1/25C12Q1/34A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,932,621
App. No.
13/808,706
Granted
Apr 3, 2018
Kind
B2
Abstract

Sirt5, a mitochondrial Sirtuin, has been identified herein as an efficient demalonylase and desuccinylase. Disclosed herein are assays to identify Sirt5 modulators based on this robust enzymatic activity. Sirt5-specific modulators can be used study the biological function of Sirt5 and to target Sirt5 activities in treating human diseases.

Claims (27)

1. A method for identifying a modulator of Sirt5 demalonylase or desuccinylase activity, comprising:

providing a candidate compound;

providing a substrate comprising a malonyl or succinyl lysine linked to an indicator moiety;

contacting the substrate with Sirt5 in the presence of the candidate compound and in the presence of nicotinamide adenine dinucleotide (NAD) under conditions for Sirt5 to demalonylate or desuccinylate the substrate;

contacting the demalonylated or desuccinylated substrate with a cleavage agent that cleaves the linkage between the lysine and the indicator moiety to release the indicator moiety, thereby generating a detectable signal; and

correlating signal intensity with Sirt5 demalonylase or desuccinylase activity;

wherein a change in Sirt5 demalonylase or desuccinylase activity in the presence of the candidate compound, relative to Sirt5 demalonylase or desuccinylase activity in the absence of the candidate compound, identifies the candidate compound as a modulator of Sirt5 demalonylase or desuccinylase activity.

2. The method of claim 1 , wherein the substrate is a peptide comprising a malonyl or succinyl lysine covalently linked to the indicator moiety through a peptide bond.

3. The method of claim 2 , wherein the cleavage agent is a proteolytic enzyme.

4. The method of claim 3 , wherein the proteolytic enzyme is trypsin.

5. The method of claim 1 , wherein the indicator moiety has fluorescent properties.

6. The method of claim 5 , wherein the indicator moiety comprises a fluorophore which changes its emission wavelength upon the cleavage and release of the indicator moiety.

7. The method of claim 5 , wherein the indicator moiety comprises a fluorophore and the substrate is also labeled with a quenching group, and upon cleavage from the substrate, the indicator moiety generates a fluorescent signal.

8. The method of claim 5 , wherein the indicator moiety comprises a fluorophore which is one member of a donor-acceptor fluorophore pair and is attached to the carboxyl terminus of the lysine residue, and the other member of the pair is attached directly or indirectly to the amino terminus of the lysine residue.

9. The method of claim 8 , wherein cleavage of the indicator fluorophore from the substrate reduces FRET-based signal intensity.

10. The method of claim 5 , wherein the indicator moiety is AMC.

11. The method of claim 10 , wherein the substrate is ISGASE(SuK)-AMC (SEQ ID NO: 11).

12. The method of claim 1 , wherein the candidate compound is a small molecule.

13. The method of claim 12 , wherein the candidate compound has the formula:

wherein:

R 1 is an anionic or ionizable group;

R 2 is selected from S, NR 5 , and O, wherein R 5 is H, methyl, ethyl, isopropyl, phenyl, or benzyl;

when R 1 is carboxyl, then R 2 is not O, and when R 2 is O, then R 1 is not carboxyl;

X 0 , X 1 , X 2 , X 3 , X 4 , X 5 , X 6 and X 7 are independently selected from —(CH 2 ) n —, wherein n represents 1, 2, or 3, —NR 5 —, —O—, —S—, or a bond, provided that at least one of X 0 -X 4 is not a bond, and at least one of X 5 -X 7 is not a bond;

R 3 and R 4 are independently selected from H, hydrocarbon (R), amino acid, dipeptide, tripeptide, oligopeptide, protein, nucleobase, nucleotide, dinucleotide, trinucleotide, oligonucleotide, monosaccharide, disaccharide, oligosaccharide, and protecting groups or a combination thereof or modified form thereof.

14. The method of claim 1 , further comprising testing the ability of the candidate molecule to affect deacetylation activity of any of Sirt 1, 2, or 3.

15. The method of claim 13 , wherein R 2 is S.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 27, 2018
From: CORNELL UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045448/0754 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2013
From: LIN, HENING
To: CORNELL UNIVERSITY
Reel/Frame 029577/0664 →
Continuity (2)
Provisional Application 61362078 · Jul 7, 2010
Related Publication 20150057236A1 · Feb 26, 2015